Patients with a newly identified tumor state had shorter survival following chemotherapy and immunotherapy, potentially helping doctors identify those at greater risk of poor outcomes.
|Articles|January 14, 2022
KidneyCAN YouTube Channel
KidneyCan hosts a YouTube channel where research news, patient education, and legislative advocacy videos keep our community connected to the latest developments.
Advertisement
KidneyCan hosts a YouTube channel where research news, patient education, and legislative advocacy videos keep our community connected to the latest developments.
Advertisement
Related to this article
Longer follow-up of the phase 2 LUNAR trial showed a 62% lower risk of progression, additional hormone therapy or death with 177Lu-PNT2002 plus radiation.
Medicare's cap on out-of-pocket drug costs has made cancer pills more affordable, but premiums, formularies and prior authorization rules still vary widely. Here's a checklist.
After two cancer diagnoses and major surgery, a liver cancer survivor shares why asking questions, exploring treatment options and advocating for your care matter.
A custom mRNA vaccine is the first to succeed in a phase 3 trial. Learn how personalized cancer vaccines work and what to watch for at ESMO 2026.
A rising PSA after surgery or radiation can be frightening. Learn what biochemical recurrence means, which tests come next and your treatment options.
Three doctors dismissed Christine Kushner’s breast changes at 37. Trusting her gut and pushing for a mammogram helped save her life.
Six years after a B-cell ALL diagnosis at 21, William Yank shares how his view of therapy changed and why he is still working on his mental health.
Advertisement
Advertisement
Trending on CURE
1
Radioligand Plus Radiation Delays Prostate Cancer Progression to 17.6 Months
2
What Is a Personalized Cancer Vaccine? What Patients Should Know
3
Medicare Open Enrollment Starts Oct. 15. What to Check If You Have Cancer
4
ESMO 2026 Preview: 5 Late-Breaking Trials Patients Should Watch
5